IMC Chicago’s Ascendis Pharma A/S ASND Stock Holding History

IMC Chicago’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-113,682	Closed	-$25.5M	–	5699
2025 Q4	$24.2M	Buy	+113,682	New	+$23.5M	0.01%	761

Other funds holding ASND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

IMC Chicago's ASND Position: Q1 2026 in Review

IMC Chicago sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 113,682 shares — an estimated $25.5M sold.

IMC Chicago first reported a position in ASND in Q4 2025 and held it in 1 quarter. The position peaked at $24.2M in Q4 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

IMC Chicago reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 113,682 Ascendis Pharma A/S shares in Q1 2026, an estimated $25.5M.
IMC Chicago first reported a position in Ascendis Pharma A/S in Q4 2025 and held it in 1 quarter.
IMC Chicago's Ascendis Pharma A/S position peaked at $24.2M in Q4 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.